SPONSORSHIP AGREEMENTTHIS AGREEMENT, dated for reference March 13, 1996, is madeBETWEEN: HEALTHCARE CAPITAL CORP., a corporation incorporated pursuant to the laws of the Province of Alberta and having an office located at 1120-595 Howe Street, Vancouver, British Columbia, V6B 1N2 (the "Issuer");AND: C.M. OLIVER COMPANY LIMITED, a company amalgamated under the laws of British Columbia, having its head office at the 2nd Floor, 750 West Pender Street, Vancouver, British Columbia, V6C 1B5 (the "Sponsor").WHEREAS:A. The Issuer wishes to distribute to residents of British Columbia and Albertaunits, comprised of one common share and one share purchase warrant, to beissued on the exercise of previously issued special warrants, on the terms andconditions described in the prospectus of the Issuer to be filed with theBritish Columbia Securities Commission and the Alberta Securities Commission(the "Prospectus");B. The Sponsor is an investment dealer based in Vancouver and is a member of theVancouver, Alberta, Toronto and Montreal stock exchanges and of the PacificDistrict of the Investment Dealers Association of Canada, and is registered as adealer under the Securities Act (British Columbia);C. The Sponsor is prepared, on and subject to the terms and conditions of thisAgreement, to conduct an investigation of the organization, management, businessand affairs of the Issuer, sufficient to enable it to sign the certificate forthe final Prospectus of the Issuer.THEREFORE, the parties agree:1. INTERPRETATION1.1 Defined TermsIn this Agreement:AG2432.386 [097] - 2 - (a) "Distribution" means the distribution by the Issuer of the Units to holders of the Securities under the Prospectus and "distribute" has a corresponding meaning; (b) "Finders Special Warrants" means the Special Warrants issued by the Issuer as a finders fee pursuant to a private placement completed by the Issuer on February 28, 1996; (c) "Indemnified Parties" means the Sponsor, its affiliates and their respective directors, officers, employees and agents; (d) "Issuer" means HealthCare Capital Corp.; (e) "Marketing Materials" means any marketing materials to be used in connection with the Offering; (f) "material change", "material fact" and "misrepresentation" have the respective meanings assigned in the Securities Act (British Columbia); (g) "Offering" means the offering, sale and distribution of the Securities pursuant to the Prospectus; (h) "Prospectus" means the final prospectus of the Issuer to be filed with the Securities Commissions in connection with the Offering; (i) "Related Agreements" means any contract which may be regarded as material to the purchase of Securities, each as more particularly described in the Prospectus; (j) "Securities" means the 1,870,000 Units of the Issuer issuable pursuant to the Special Warrants and additional 35,750 Units of the Issuer issuable pursuant to the Finders Special Warrants offered under the Prospectus; (k) "Securities Commissions" means the Alberta Securities Commission and the British Columbia Securities Commission; (l) "Securities Law" means collectively the applicable laws, regulations, policies and prescribed forms of Alberta and British Columbia relating to the distribution of the Securities; (m) "Security Holder" means any person whose subscription for Securities is accepted by the Issuer, or any subsequent transferee or successor of such person; (n) "Sponsor" means C.M. Oliver Company Limited; andAG2432.386 [097] - 3 - (o) "Special Warrants" means the outstanding special warrants of the Issuer each such special warrant entitling the acquisition of one common share and one non-transferable share purchase warrant to purchase one additional common share in the capital of the Issuer.1.2 Accounting TermsAny accounting terms used herein which are not specifically defined in thepreceding section 1.1 shall be construed in accordance with generally acceptedCanadian accounting principles.1.3 Number and GenderWords importing the singular number include plural and vice versa and wordsimporting gender include the masculine, feminine and neuter genders.1.4 HeadingsThe division of this Agreement into sections, subsections, paragraphs,subparagraphs, schedules and clauses, and the insertion of headings and captionsare for convenience of reference only and do not affect the construction orinterpretation of this Agreement.1.5 SeverabilityAny provision of this Agreement which may be found to be prohibited by orunenforceable pursuant to the laws of any jurisdiction shall, as to suchjurisdiction, be ineffective to the extent of such unenforceability orprohibition without invalidating the remaining terms and provisions hereof.1.6 Certificates and Certified CopiesWhenever in this Agreement reference is made to a certificate or a certifiedcopy to be delivered by a party, unless specifically provided otherwise, suchcertificate or certified copy must be executed by an officer of the party who,by virtue of his office, is familiar with the subject of such certificate orcertified copy and shall certify the completeness, truth and accuracy thereof asof the date of such certificate or certified copy.1.7 Governing LawThis Agreement is governed by, and will be construed in accordance with, thelaws of British Columbia, Canada.1.8 Entire AgreementAG2432.386 [097] - 4 -This Agreement, including any thing expressly incorporated by reference herein,contains all the terms and conditions in connection with the subject matterhereof and no other agreements, written or oral, respecting such subject mattershall be deemed to exist or to bind any party.1.9 Currency ReferencesAll dollar amounts referred to in this Agreement are in Canadian dollars unlessotherwise specifically provided.2. APPOINTMENT OF SPONSOR2.1 Appointment of SponsorThe Issuer appoints the Sponsor as sponsor of the Offering and the Sponsoraccepts the appointment and agrees to act as sponsor of the Issuer under theProspectus on the terms of this Agreement.2.2 Duties of SponsorAs sponsor of the Issuer under the Prospectus, the Sponsor will conduct aninvestigation of the organization, management, business and affairs of theIssuer sufficient, in its sole discretion, to enable it to determine whether ornot it is able to sign the certificate of the Prospectus.2.3 Signature of CertificateIf, following the investigation referred to in subsection 2.2, the Sponsordetermines in its sole discretion that it is able to do so, the Sponsor willsign the certificate for the Prospectus, certifying that, to the best of itsknowledge, the Prospectus contains full, true and plain disclosure of allmaterial facts relating to the Securities.2.4 Review of BusinessThe Issuer will provide, or cause to be provided, to the Sponsor, its counseland its agents a reasonable opportunity to conduct such full and comprehensivereview of its business, capital, finances, operations and principals as theSponsor, in its sole discretion, considers reasonably necessary in thecircumstances.2.5 Sponsors FeeFor the services of the Sponsor as sponsor of the Offering and as full andcomplete compensation therefor, the Issuer will pay to the Sponsor the sum of32,100 (inclusive of Goods and Services Tax), the receipt of which isacknowledged by the Sponsor.AG2432.386 [097] - 5 -3. REPRESENTATIONS AND WARRANTIES3.1 Representations and Warranties of the IssuerThe Issuer represents and warrants to the Sponsor that: (a) Status of the Issuer The Issuer, and each of its subsidiaries, is a corporation duly incorporated, validly existing and in good standing under the respective laws of the jurisdiction of its incorporation and each has all requisite power and authority and holds all material licences, certificates, consents, permits and other authorizations as are necessary to enable it to carry on its proposed business as disclosed in the Prospectus. (b) Regular Business The business of the Issuer and its subsidiaries have been carried on, in all material respects, as contemplated by and in compliance with the requirements of their respective constating documents and in compliance with all applicable laws, rules and regulations, and neither the Issuer nor any of its subsidiaries is in breach of or in default under any mortgage, note, indenture, contract, instrument, lease or other document or agreement to which it is a party. (c) Corporate and Partnership Authority The execution, delivery and performance by the Issuer of this Agreement and the Related Agreements, when executed and delivered, to which it is or will be a party are within the Issuers powers, have been or will have been, at the time of execution and delivery thereof, duly authorized by all necessary corporate action and do not and will not contravene its constating documents or any provision of any contract binding on it. (d) Claims and Potential Claims To the knowledge of the Issuer, no litigation, proceeding or investigation is pending or threatened before any court, agency, arbitrator or otherwise which will or might reasonably result in any material adverse change in the business, affairs or properties or conditions (financial or otherwise) of the Issuer or any of its subsidiaries or which might reasonably result in any material liability on the part of the Issuer or any of its subsidiaries.AG2432.386 [097] - 6 - (e) Prospectus The Prospectus complies with the requirements of the Securities Law in all material respects. The Prospectus does not contain any misrepresentation or any untrue statement of a material fact or omit any statement or information, the omission of which constitutes a misrepresentation, or omit to state any material fact required to be stated or necessary to make any statement contained therein not false or misleading in light of the circumstances in which it is made and all information and statements contained in the Prospectus are true and correct. In addition, all information and statements contained in the Prospectus constitute full, true and plain disclosure of all material facts. (f) Financial Statements The financial statements of the Issuer contained in the Prospectus accurately reflect the financial position of the Issuer on a consolidated basis at the dates thereof and there have been no adverse material changes in the financial position of the Issuer or any of its subsidiaries since the respective dates thereof, except as fully and plainly disclosed in the Prospectus. (g) Representations and Warranties The representations and warranties in this Agreement are true and will remain true as of the date of the Prospectus.3.2 Representations and Warranties of the SponsorThe Sponsor represents and warrants to the Issuer that: (a) Corporate Status It is a corporation duly amalgamated, validly existing and in good standing under the laws of British Columbia. (b) Corporate Authority The execution, delivery and performance by the Sponsor of this Agreement is within the Sponsors corporate powers, has been duly authorized by all necessary corporate action and does not contravene: (i) the memorandum or articles of the Sponsor; or (ii) any law; orAG2432.386 [097] - 7 - (iii) any provision of any other contract binding on the Sponsor. (c) Governmental Approvals Except for compliance with the requirements of the Securities Law, no authorization or approval or other action by and no notice to or filing with any governmental authority or regulatory body is required for the due execution, delivery and performance by the Sponsor of this Agreement.3.3 Survival of Representations and WarrantiesEach of the parties hereto acknowledges that the other parties are relying oneach of the representations and warranties addressed to such other parties setforth in section 3.1 or 3.2, as the case may be, and any representations made inany certificate issued to such other parties in connection with this Agreementnotwithstanding any investigations heretofore or hereafter made by such otherparties or their counsel or representatives. All such representations andwarranties shall not merge in or be prejudiced by, and shall survive for aperiod of three years from the completion of the distribution of the Units.4. COVENANTS OF THE ISSUERThe Issuer covenants with the Sponsor that: (a) it will take all such acts and execute, file and deliver all such documents, amendments, notices and information as may be necessary to cause the purchasers of Securities to become Security Holders of the Issuer; (b) it will execute or procure the execution of all documents and use its best efforts to take or cause to be taken all steps which may be reasonably necessary to enable the transactions contemplated herein to be completed; (c) it will notify the Sponsor promptly in writing of the full particulars of any material change, whether actual, anticipated or threatened, in any material fact stated or referred to in the Prospectus or which would result in an omission from the Prospectus to state a material fact necessary to make any statement contained therein not misleading in light of the circumstances in which it is made; (d) during the period of distribution, distribution to the public or primary distribution to the public (as contemplated by the Securities Law) of the Securities, it will advise the Sponsor promptly of any request of any securities commission or other securities authority for a cease trading order relating to the Securities, or of the institution or threat of institution of any proceedings for that purpose, or of the receipt by it, or its counselAG2432.386 [097] - 8 - of any material communication from any securities commission or other securities authority relating to the Prospectus or any supplements or amendments thereto; (e) upon the occurrence of a material change, it shall, to the satisfaction of the Sponsor, promptly comply with all applicable filing and other requirements under the Securities Law as a result of such material change; (f) the Securities, when issued, will have the attributes described in the Prospectus; and (g) it will deliver or cause to be delivered all documents, including legal opinions, required hereunder and by the Prospectus.5. EXPERT OPINIONSThe Issuer shall deliver to the Sponsor on the date of filing the Prospectus: (a) a letter dated as of a date not more than one Business Day prior to the date of the Prospectus, in form and substance satisfactory to the Sponsor, from the then current auditor of the Issuer: (i) stating that, in such auditors opinion, the financial statements and notes thereto of the Issuer examined by them and included in the Prospectus covered by his report therein comply as to form in all material respects with the applicable accounting requirements of the Securities Law; and (ii) stating that, in such auditors opinion, the balance sheet of the Issuer examined by the auditor and included in the Prospectus and covered by his report therein complies as to form in all material respects with the applicable accounting requirements of the Securities Law; and (iii) addressing such other matters relating to the financial information in the Prospectus to which the Sponsor may reasonably require comfort; (b) a favourable legal opinion, in form and content reasonably satisfactory to the Sponsor, by counsel to the Issuer dated the date of the Prospectus and addressed to the Sponsor, relating to such legal matters as the Sponsor may reasonably request, including, without limitation, certain of the matters in section 3.1, title to the Issuers property, and matters pertaining to the Securities Law;AG2432.386 [097] - 9 - (c) a certificate of the Issuer certifying certain facts relating to the business of the Issuer, and its affairs as may be reasonably requested by the Sponsor; and (d) any other certificates, comfort letters or opinions in connection with any matter related to the Prospectus which are reasonably requested by the Sponsor or their legal counsel.6. TERMINATION6.1 Term of AgreementThis Agreement shall terminate and, subject to the provisions set forth below,be of no further force or effect on the exercise by the Sponsor of its right toterminate this Agreement as provided in subsection 6.2, provided that, in anyevent, sections 3, 7 and 8 and, in the event that such termination occurs byvirtue of paragraph 6.2(b), subsection 2.5 shall not terminate (except as setforth therein) and shall continue in full force and effect for the benefit ofthe Sponsor or the other parties to this Agreement, as the case may be.6.2 Termination of AgreementThe Sponsor may, at its sole option, terminate this Agreement at any time priorto the issuance of a receipt for the Prospectus by all of the SecuritiesCommissions by notice in writing to the Issuer if: (a) any representation or warranty made by or on behalf of the Issuer herein or in any certificate delivered in connection with this Agreement proves to have been incorrect in any material respect when made; (b) any material adverse change occurs in the business or financial condition of the Issuer or any of its subsidiaries; (c) the Issuer breaches or fails to perform or observe any of the covenants or agreements to be performed or observed by it hereunder; (d) any order operating to restrict, prevent or cease trading in the Securities is made under the Securities Law; (e) any inquiry or investigation, whether formal or informal, is commenced or threatened by a securities commission against the Issuer or its directors, officers or agents; or (f) any of the conditions set forth in section 5 are not satisfied.AG2432.386 [097] - 10 -6.3 Obligations of Sponsor ClarifiedFor greater certainty, the Sponsor is obligated under this Agreement, subject tosubsection 6.2, only to perform the investigation referred to in subsection 2.2,and nothing in this Agreement will obligate the Sponsor to sign the certificatefor the Prospectus, unless, in its sole discretion, it considers itself able todo so.7. COSTS, EXPENSES AND TAXESWhether or not the Sponsor signs the certificate as contemplated in subsection2.3, the Issuer will bear the costs and expenses in connection with theOffering, the preparation, execution and delivery of this Agreement, amendmentsto the Prospectus and the other documents to be delivered hereunder, including,without limitation: (a) the reasonable fees and out-of-pocket expenses of counsel for the Sponsor with respect thereto (which fees, not including expenses and taxes, are not expected to exceed 15,000 but may after consultation with and receipt of the prior approval of the Issuer) and with respect to advising the Sponsor as to its rights and responsibilities under this Agreement; (b) fees and costs of preparing and reproducing the Prospectus, any amendments thereto and any other Marketing Materials prepared by the Issuer; (c) filing fees in connection with compliance with the Securities Law; (d) all costs and expenses associated with obtaining an assessment report in compliance with Interim Local Policy Statement 3-17 of the British Columbia Securities Commission, if required; and (e) all costs and expenses, if any (including reasonable counsel fees and expenses), in connection with the enforcement of this Agreement, and the other documents to be delivered hereunder.8. INDEMNIFICATION8.1 Indemnification of Indemnified PartiesThe Issuer shall and does hereby indemnify and save the Indemnified Partiesharmless from and against any liability, claim, demand or loss, excluding lossof profits, which the Indemnified Parties may suffer, whether pursuant tostatute or otherwise, howsoever arising, in consequence of:AG2432.386 [097] - 11 - (a) any statement or omission in the Prospectus, or otherwise made or omitted by the Issuer in connection with the Offering, being or being alleged to be a misrepresentation; (b) the Issuer not complying with any requirement of applicable legislation of Canada or of British Columbia or Alberta; or (c) any order made or any inquiry, investigation or proceeding commenced, threatened or announced by any securities regulatory authority or other competent authority in British Columbia, Alberta or Ontario which prevents or restricts trading in or the sale or distribution in British Columbia and Alberta of the Securities.8.2 Right to CounselIf any claim contemplated by this section is asserted against any of theIndemnified Parties, the Issuer shall be entitled (but not required) to assumethe defence on behalf of the Indemnified Parties of any suit brought to enforcesuch claim, provided that the defence shall be through legal counsel acceptableto the Indemnified Parties and no admission of liability shall be made by theIssuer or the Indemnified Parties without, in each case, the prior writtenconsent of all the parties hereto, such consent not to be unreasonably withheld.Any of the Indemnified Parties shall have the right to employ separate counselin any such suit and participate in the defence thereof, at the expense of theIssuer.8.3 IndemnityThe indemnity provided for in this section will not be limited or otherwiseaffected by any other indemnity obtained by the Sponsor from any other person inrespect of any matters specified in this Agreement and will continue in fullforce and effect until all possible liability of the Sponsor arising out of thetransactions contemplated by this Agreement has been extinguished by theoperation of law.9. NOTICESAny notice required or permitted to be given hereunder shall be in writing andbe given by personal service, telex, telegram, telecopy or by registered letter,with postage fully prepaid, to the address set forth below:AG2432.386 [097] - 12 - (a) if to the Issuer at: HealthCare Capital Corp. c/o Ballem MacInnes Barristers and Solicitors First Canadian Centre 1800, 350-7th Avenue S.W. Calgary, Alberta T2P 3N9 Attention: William DeJong Telephone: (403) 292-9800 Fax: (403) 233-8979 (b) if to the Sponsor at: C.M. Oliver Company Limited 2nd Floor, 750 West Pender Street Vancouver, B.C. V6C 1B5 Attention: Lyle Davis Telephone: (604) 668-6700 Fax: (604) 681-8964Any notice delivered personally or by telex, telegram or telecopy shall bedeemed to be received by and given to the addressee on the day of delivery. Anynotice mailed as aforesaid shall be deemed to have been received by and given tothe addressee on the fifth Business Day following the date of mailing except inthe event of a disruption of postal service, in which event notice shall bedelivered personally or given by telex, telegram or telecopy. Either partyhereto may designate a new address by giving written notice thereof to the otherparty at least ten days in advance of the effective date of such designation.10. MISCELLANEOUS10.1 Amendments, Etc.No amendment or waiver of any provision of this Agreement nor consent to anydeparture by the Issuer therefrom shall in any event be effective unless it isin writing and signed by the Sponsor and then such waiver or consent will beeffective only in the specific instance and for the specific purpose for whichgiven.10.2 TimeTime shall be of the essence of this Agreement.AG2432.386 [097] - 13 -10.3 Binding EffectThis Agreement is binding upon and enures to the benefit of the parties andtheir respective successors and assigns, and no party shall have the right toassign its rights hereunder or any interest herein without the prior writtenconsent of the other parties.10.4 Governing LawThis Agreement will be governed by the law of British Columbia and the partiesattorn to the non-exclusive jurisdiction of the courts of British Columbia forthe resolution of all disputes arising in connection with this Agreement.11. EXECUTION IN COUNTERPARTThis Agreement may be executed by any party in two or more counterparts, eachsuch counterpart will be deemed to be an original, and all such counterpartstaken together will constitute one and the same agreement.IN WITNESS of this Agreement, the parties have executed and delivered thisAgreement as of the date given above.HEALTHCARE CAPITAL CORP.By: /s/ Douglas F. GoodTitle: Chief Financial OfficerC.M. OLIVER COMPANY LIMITEDBy: /s/ C. M. OBrianTitle: ChairmanAG2432.386 [097]